Elpi Lip
Long-acting hypolipemiant Indicated to treat hypercholesterolemia (Type Lia) and endogenous hypertriglyceridemia, isolated (type IV) or associated (type IIb and III).
Therapeutic Area
Hypolipemiant
Active Ingredient
Bezafibrate
Line
Cardiometabolism
Pharmaceutical Form
400 mg extended-release tablets x 30
